Truepill provides API-driven, white-label pharmacy and nationwide prescription fulfillment services that enable partners to deliver modern, digital-first consumer healthcare experiences. The company offers prescription fulfillment and delivery, white-label packaging, product design, and operates a network of owned pharmacies and fulfillment centers with multiple accreditations (URAC, NABP, FDA registration). Truepill reports double-digit growth through its market-leading APIs and powers customers such as Mark Cuban Cost Plus Drugs, GoodRx, Levels, and a leading pharmaceutical manufacturer. The business is investing in operational expansion, including a new high-volume facility in Cincinnati, Ohio—its ninth location—to expand fulfillment capacity. Leadership changes include promotion of Paul Greenall to President to align customer retention and growth with expanded operational capabilities. Truepill was founded in 2016 and is based in San Mateo, Calif. Truepill built a consumer-facing network of telehealth, diagnostics and virtual pharmacy services and has expanded into B2B work with health plans, payers, providers and employer groups. Since its Series C launch of telehealth and diagnostics, the company has also rolled out a COVID-19 wellness program and virtual pharmacy e-commerce. Operational metrics cited include nearly 10 million prescriptions shipped, roughly 1 million diagnostic tests processed, and more than 50,000 telehealth visits per week. Management says the business is positioned to bring in about $300 million in revenue this year. The new funding will support hiring across engineering, business development and pharmacy and the opening of six new pharmacy and over-the-counter fulfillment facilities in California, Illinois, Michigan, North Carolina, Ohio and Pennsylvania by next year. The company is shifting from a primarily direct-to-consumer focus to also serving healthcare incumbents and larger enterprise customers. Truepill is an API-connected healthcare infrastructure company that offers customized B2B solutions for healthcare companies, including a telehealth network, pharmacy fulfillment, and a custom-built EMR. Led by CEO and co-founder Umar Afridi and co-founder and president Sid Viswanathan, the company serves direct-to-consumer health brands as customers expand offerings and enter new markets. Truepill operates owned pharmacies in Hayward, CA; Brooklyn, NY; Redmond, WA; Alhambra, CA; Austin, TX; and Manchester, England, and holds accreditations including URAC mail order and specialty pharmacy accreditations, NABP, Digital Pharmacy Accreditation and LegitScript. The company raised a $75M Series C to expand its network and launch a new at-home lab testing service by the end of the year. The at-home lab testing network will be combined with telehealth and prescription delivery to enable diagnosis and management of major chronic conditions such as diabetes, heart disease, and chronic kidney disease. Truepill continues enhancing its platform through APIs to support a broader ecosystem of direct-to-patient capabilities. Truepill provides API technology and services that enable B2B customers to build direct-to-patient healthcare experiences. Its platform includes nationwide pharmacy fulfillment and delivery, a US-based network of licensed telehealth practitioners, white-label product design and related services. The company reports pharmacies with capacity to deliver 100,000 prescriptions per day and clinicians who can diagnose and prescribe across all 50 states. Customers include GoodRx, TherapeuticsMD, K Health, hims & hers, Nurx and Simple Health. Truepill plans to use new capital to expand adoption of its direct-to-patient solutions, grow its product offerings and continue investing in its portfolio of consumer health brands. As of this round the company has raised more than $39 million in venture funding and operates owned pharmacies in Hayward, CA; Brooklyn, NY; Redmond, WA; Alhambra, CA; Austin, TX; and Manchester, England. Truepill is an online pharmacy infrastructure provider that powers prescription delivery for direct-to-consumer healthcare brands such as Hims, Nurx and LemonAID. It operates a prescription delivery service and provides APIs that give customers programmatic access to its pharmacy and allow brands to fully customize packaging. Co‑founders describe the business as the "AWS for pharmacies." Founded in 2016 and based in San Mateo, Truepill is active in all 50 states and has delivered 1 million subscriptions for birth control, erectile dysfunction medication, hair-loss treatment and more. The company employs about 150 workers and plans to expand its team and fulfillment facilities into the U.K. with the new funding. To date it has raised $13.4 million in total funding.

Total raised

$252M

Funding rounds

5

Latest round

Series D

Latest activity

Oct 2021